跳至主要内容
临床试验/CTRI/2016/03/006736
CTRI/2016/03/006736已完成4 期

Prospective study of role of thromboembolic prophylaxis with low molecular weight heparin or Aspirin plus intermittent compression devices undergoing Total Hip and Knee Arthroplasty

All India Institute of Medical Sciences0 个研究点目标入组 300 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Indian patients undergoing hip and knee arthroplasty

排除标准

  • patients aged <18 or > 90 years, patients with coagulation or bleeding disorders, hypersensitivity to aspirin or low molecular weight heparin, Heparin induced thrombocytopenia, history of thromboembolic disease/ chronic venous insufficiency, ocular or neurosurgical procedure during last 3 month, active peptic ulcer disease, severe renal insufficiency, systolic hypertension >200 mm Hg, pulmonary tuberculosis, a solid malignancy tumor, active Liver disease, peripheral vascular disease , and who refused to give consent.

研究者

相似试验